330 related articles for article (PubMed ID: 25346912)
1. Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients.
Tian S; Hirshfield KM; Jabbour SK; Toppmeyer D; Haffty BG; Khan AJ; Goyal S
Front Oncol; 2014; 4():277. PubMed ID: 25346912
[TBL] [Abstract][Full Text] [Related]
2. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
3. The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer Therapy.
Henri C; Heinonen T; Tardif JC
Biomark Cancer; 2016; 8(Suppl 2):39-45. PubMed ID: 27257396
[TBL] [Abstract][Full Text] [Related]
4. Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.
Gulati G; Heck SL; Røsjø H; Ree AH; Hoffmann P; Hagve TA; Norseth J; Gravdehaug B; Steine K; Geisler J; Omland T
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29118031
[TBL] [Abstract][Full Text] [Related]
5. Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis.
Michel L; Mincu RI; Mahabadi AA; Settelmeier S; Al-Rashid F; Rassaf T; Totzeck M
Eur J Heart Fail; 2020 Feb; 22(2):350-361. PubMed ID: 31721381
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers as Predictors of Cardiac Toxicity From Targeted Cancer Therapies.
Witteles RM
J Card Fail; 2016 Jun; 22(6):459-64. PubMed ID: 27038641
[TBL] [Abstract][Full Text] [Related]
7. Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis.
Michel L; Mincu RI; Mrotzek SM; Korste S; Neudorf U; Rassaf T; Totzeck M
ESC Heart Fail; 2020 Apr; 7(2):423-433. PubMed ID: 32069386
[TBL] [Abstract][Full Text] [Related]
8. Left Ventricular Systolic Dysfunction Predicted By Early Troponin I Release After Anthracycline Based Chemotherapy In Breast Cancer Patients.
Shafi A; Siddiqui N; Imtiaz S; Din Sajid MU
J Ayub Med Coll Abbottabad; 2017; 29(2):266-269. PubMed ID: 28718245
[TBL] [Abstract][Full Text] [Related]
9. Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: A narrative review.
Simões R; Silva LM; Cruz ALVM; Fraga VG; de Paula Sabino A; Gomes KB
Biomed Pharmacother; 2018 Nov; 107():989-996. PubMed ID: 30257411
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for the early detection of anthracycline-induced cardiotoxicity: current status.
Horacek JM; Vasatova M; Pudil R; Tichy M; Zak P; Jakl M; Jebavy L; Maly J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):511-7. PubMed ID: 24457832
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline or trastuzumab-related cardiotoxicity: do we have a predictive biomarker?
Chaudry M; Banchs J; Chavez-MacGregor M
Biomark Med; 2016; 10(3):315-28. PubMed ID: 26860187
[TBL] [Abstract][Full Text] [Related]
12. Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.
Christenson ES; James T; Agrawal V; Park BH
Clin Biochem; 2015 Mar; 48(4-5):223-35. PubMed ID: 25445234
[TBL] [Abstract][Full Text] [Related]
13. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for monitoring chemotherapy-induced cardiotoxicity.
Cao L; Zhu W; Wagar EA; Meng QH
Crit Rev Clin Lab Sci; 2017 Mar; 54(2):87-101. PubMed ID: 28013560
[TBL] [Abstract][Full Text] [Related]
15. Are Biomarkers Predictive of Anthracycline-Induced Cardiac Dysfunction?
Malik A; Jeyaraj PA; Calton R; Uppal B; Negi P; Shankar A; Patil J; Mahajan MK
Asian Pac J Cancer Prev; 2016; 17(4):2301-5. PubMed ID: 27221934
[TBL] [Abstract][Full Text] [Related]
16. Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.
Jacob S; Pathak A; Franck D; Latorzeff I; Jimenez G; Fondard O; Lapeyre M; Colombier D; Bruguiere E; Lairez O; Fontenel B; Milliat F; Tamarat R; Broggio D; Derreumaux S; Ducassou M; Ferrières J; Laurier D; Benderitter M; Bernier MO
Radiat Oncol; 2016 Apr; 11():54. PubMed ID: 27056179
[TBL] [Abstract][Full Text] [Related]
17. Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity.
Germanakis I; Anagnostatou N; Kalmanti M
Pediatr Blood Cancer; 2008 Sep; 51(3):327-33. PubMed ID: 18523992
[TBL] [Abstract][Full Text] [Related]
18. Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers.
Chen D; Kelly C; Haw TJ; Lombard JM; Nordman IIC; Croft AJ; Ngo DTM; Sverdlov AL
Curr Heart Fail Rep; 2021 Dec; 18(6):362-377. PubMed ID: 34731413
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity.
Mahjoob MP; Sheikholeslami SA; Dadras M; Mansouri H; Haghi M; Naderian M; Sadeghi L; Tabary M; Khaheshi I
Cardiovasc Hematol Disord Drug Targets; 2020; 20(1):74-83. PubMed ID: 31513000
[TBL] [Abstract][Full Text] [Related]
20. Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients.
Srikanthan K; Klug R; Tirona M; Thompson E; Visweshwar H; Puri N; Shapiro J; Sodhi K
J Clin Exp Cardiolog; 2017 Mar; 8(3):. PubMed ID: 28642833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]